Jefferies has downgraded Amicus Therapeutics to 'Buy' from 'Hold' and trimmed its price target to $14.50, aligning it with BioMarin's pending $4.8 billion acquisition offer. The move reflects analyst skepticism about competing bids emerging for the rare disease biotech firm.
Oracle is launching a massive $45-$50 billion capital raise to aggressively expand its cloud infrastructure, fueled by long-term contracts with AI giants like OpenAI, NVIDIA, and Meta. The move underscores the fierce competition in the cloud arms race, even as the company's stock faces recent headwinds.
Homebuilder LGI Homes is testing a higher-specification housing model with the launch of its Monte Vista community in Modesto, California. The new single-story homes come with significant included upgrades and integrated solar energy systems, signaling a strategic shift towards energy efficiency and long-term cost-conscious buyers.
Norwegian energy giant Equinor is selling its onshore shale assets in Argentina's Vaca Muerta formation to local operator Vista Energy, marking a strategic pivot as it doubles down on offshore exploration and core international markets.
The tech giant plans a colossal capital raise through debt and equity to expand its cloud infrastructure, aiming to meet surging demand from major AI players amid growing investor scrutiny over spending.
American Airlines begins compensating flight attendants left without accommodations during Winter Storm Fern, as the union accuses management of contract violations and calls for accountability.
The payments giants Visa and Mastercard reported robust revenue and earnings growth for their latest quarters, though their premium valuations continue to spark investor debate on which offers the superior long-term opportunity.
Pharmaceutical giant Eli Lilly enters a strategic collaboration potentially worth up to $1.93 billion with biotech firm Repertoire Immune Medicines, aiming to develop precision treatments for autoimmune diseases that move beyond broad immunosuppression.
The probate process can drain an estate's assets and burden heirs for years. Financial and legal experts outline practical steps families can take now to ensure a smoother transfer of wealth.
Terns Pharmaceuticals has restructured a key licensing deal with China's Hansoh, gaining exclusive worldwide rights for its TERN-701 oncology drug outside Greater China. The strategic move, coupled with a recent analyst price target surge, signals the company's aggressive push into international markets.
Fidelity data reveals the average millennial 401(k) balance stands at $67,300. While the figure may seem modest, financial experts argue it represents a solid foundation for a generation that entered the workforce during economic turmoil.
India's latest budget proposal maintains its stringent 30% tax on crypto gains and 1% TDS, while introducing a new penalty regime for non-compliance with transaction reporting, including daily fines and a flat $545 charge for errors.
While investors chase pure-play AI stocks, cybersecurity leader CrowdStrike demonstrates how leveraging AI defensively within a robust platform model can drive sustained, profitable growth amid escalating digital threats.
Global Partners LP reaffirms its quarterly cash distribution while issuing detailed U.S. tax withholding guidance for international investors, putting a spotlight on the balance between income reliability and the complexities of after-tax returns in a challenging market.
The Portuguese government has launched a massive financial aid package, combining loans and direct support, to accelerate recovery from the deadly Storm Kristin which left a trail of destruction across the country last week.
Minerals 260 (ASX:MI6) has significantly upgraded the resource estimate at its Bullabulling gold project to 4.5 million ounces, bolstered by strong drilling results and a solid cash position. The expansion shifts focus to the upcoming pre-feasibility study and execution risks as the company targets key development decisions by 2026.
Veralto Corp. is set to report fourth-quarter earnings after Tuesday's market close, with investors watching for signs of sustained growth in water analytics and treatment demand. The report comes amid mixed signals from the broader environmental services sector.
As artificial intelligence drives an unprecedented surge in electricity demand, one utility company—Constellation Energy—is uniquely positioned with its vast nuclear fleet to meet the need, turning an industry-wide bottleneck into a significant growth opportunity.
From split boxes to crushed pallets, transit damage remains a multi-billion dollar drain on global supply chains. We examine the systemic mismatches between packaging design and the harsh realities of modern logistics.
Idorsia's exclusive licensing agreement with EMS to commercialize insomnia drug QUVIVIQ across Latin America marks a key step in its global expansion. The deal, involving $20 million in milestones and royalties, arrives as long-term data for its Fabry disease candidate lucerastat puts the spotlight on the company's broader late-stage pipeline and persistent financial pressures.
